References
  1. von Scheidt W, Welz A, Pauschinger M, Fischlein T, Schächinger V, Treede H, et al. Interdisciplinary consensus on indications for transfemoral transcatheter aortic valve implantation (TF-TAVI): Joint Consensus Document of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte e.V. (ALKK) and cooperating Cardiac Surgery Departments. Clin Res Cardiol. 2020;109(1):1-12.
  2. Levett JY, Windle SB, Filion KB, Brunetti VC, Eisenberg MJ. Meta-Analysis of Transcatheter Versus Surgical Aortic Valve Replacement in Low Surgical Risk Patients. Am J Cardiol. 2020;28: S0002-9149(20)30058-8.
  3. Vipparthy SC, Ravi V, Avula S, Kambhatla S, Mahmood M, Kabour A et al. Meta-Analysis of Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in Patients With Low Surgical Risk. Am J Cardiol. 2020;125(3):459-468.
  4. Kolte D, Vlahakes GJ, Palacios IF, Sakhuja R, Passeri JJ, Inglessis I, et al. Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients. J Am Coll Cardiol. 2019;74(12):1532-1540.
  5. D’Auria F, Casado AP, Myat A, Lorusso R, Hildick-Smith D. Long-Term Survival and Outcomes According to VARC-2 Criteria for Subclavian, Direct Aortic, Femoral, and Apical Implantation: An 8-Year United Kingdom TAVI Surgical Experience. Surg Technol Int. 2020;37: sti37/1327. Online ahead of print.
  6. Overtchouk P, Modine T. Alternate Access for TAVI: Stay Clear of the Chest. Interv Cardiol. 2018;13(3):145-15.
  7. Ruge H, Lange R, Bleiziffer S, Hutter A, Mazzitelli D, Will A, et al. First successful aortic valve implantation with the CoreValve ReValvingTM system via right subclavian artery access: a case report, Heart Surg Forum 11 (2008) E323–E324.
  8. Myat A, Papachristofi O, Trivedi U, Bapat V, Young C, de Belder A, et al. Transcatheter aortic valve implantation via surgical subclavian versus direct aortic access: A United Kingdom analysis. Int J Cardiol. 2020;308:67-72.
  9. Takagi H, Hari Y, Nakashima K, Kuno T, Ando T, ALICE (All-Literature Investigation of Cardiovascular Evidence) Group. Comparison of early and midterm outcomes after trans subclavian/axillary versus transfemoral, transapical, or transaortic transcatheter aortic valve implantation. Heart Lung. 2019;48(6):519-529.
  10. Rahhab Z, El Faquir N, Tchetche D, Delgado V, Kodali S, Mara Vollema E, et al. Expanding the indications for transcatheter aortic valve implantation. Nat Rev Cardiol. 2020;17(2):75-84.